It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Some features of ATS will be disabled while you continue to use an ad-blocker.
originally posted by: soficrow
a reply to: intrptr
The immune system is intimately connected with and responsive to the environment - so it's "strength" is all about that connectedness. In this light, "resistance" is disconnection and ultimately, a failure to thrive and survive.
originally posted by: rickymouse
Some viruses actually can kill cancer. Some viruses can kill bacteria and clean up an infection. Actually the majority of viruses are either neutral or beneficial to humans. We evolved with them. A common cold can kill cancer cells in your body.
... our gut is the powerhouse in which our body gets everything from immune boosts to mood changes to vitamin production and much more.
Protect your GUT and treat it right and it will in turn give you a much happier life.
2016. Clinical development of reovirus for cancer therapy: An oncolytic virus with immune-mediated antitumor activity
...Early clinical trials have shown a safe and tolerable toxicity profile of reovirus with a predictable NARA response, minimal viral shedding, and localization, replication, and cytotoxic effects in pathologic specimens consistent with activity. Phase II and III trials involving reovirus have demonstrated promising results of clinical efficacy and reinforce its potential as an anticancer agent. Future trials will likely take advantage of its excellent toxicity profile in combination therapies for synergistic tumor cell killing.
2014. Reovirus in cancer therapy: an evidence-based review
...Importantly, reovirus has been shown to be effective as a monotherapy, as well as in combination with other anticancer options, including radiation and chemotherapeutic agents, such as gemcitabine, docetaxel, paclitaxel, and carboplatin. ...Based on the evidence from clinical trials, we comprehensively review the use of reovirus as an anticancer agent, acknowledge key obstacles, and suggest future directions to ultimately potentiate the efficacy of reovirus oncotherapy.